A    B    C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    
Clearsynth is a leading innovator in pharmaceutical reference standards, offering high-quality Reference Standards for Buclizine, including both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Our Buclizine impurity reference standards are invaluable for pharmaceutical research, supporting product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They also aid in identifying unknown impurities and assessing genotoxic potential.
Our Buclizine-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.

Buclizine Related Compounds

Stable Isotopes

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Buclizine 13C6 Stable Isotopes CS-EK-01950 82-95-1 unlabeled Enquire
Buclizine-d8 Dihydrochloride Stable Isotopes CS-O-06448 129-74-8(Unlabeled) In Stock


API Standards

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Buclizine API Standards CS-P-00366 82-95-1 Enquire
Buclizine Dihydrochloride API Standards CS-O-03935 129-74-8 In Stock


Impurities

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Cetirizine EP Impurity A Impurities CS-O-31588 303-26-4 In Stock


Intermediates

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
4-Chlorobenzophenone Intermediates CS-O-07596 134-85-0 In Stock